{
  "page": 127,
  "value": [
    {
      "path": "_news/2021-09-08-speech-recognition-works-for-kids-and-its-about-time.md",
      "title": "Speech recognition works for kids, and it’s about time",
      "excerpt": "Margery Mayer served for 25 years as president of education at Scholastic. Speech recognition technology is finally working for kids. That wasn’t the case back in 1999, when my colleagues at ...",
      "sourceUrl": null,
      "webUrl": "https://techcrunch.com/2021/09/07/speech-recognition-works-for-kids-and-its-about-time/",
      "originalUrl": "https://techcrunch.com/2021/09/07/speech-recognition-works-for-kids-and-its-about-time/",
      "featuredContent": null,
      "highlight": null,
      "heat": null,
      "tags": null,
      "images": [
        {
          "url": "https://techcrunch.com/wp-content/uploads/2021/09/GettyImages-525848879.jpg?w=1024",
          "width": 1024,
          "height": 682,
          "title": null,
          "attribution": null,
          "isCached": true
        }
      ],
      "content": "\r\n",
      "type": "article",
      "ampWebUrl": "https://techcrunch.com/2021/09/07/speech-recognition-works-for-kids-and-its-about-time/amp/",
      "cdnAmpWebUrl": "https://techcrunch-com.cdn.ampproject.org/c/s/techcrunch.com/2021/09/07/speech-recognition-works-for-kids-and-its-about-time/amp/",
      "publishedDateTime": "2021-09-07T11:02:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "TechCrunch",
        "domain": "techcrunch.com",
        "images": [
          {
            "url": "https://everyday-cc.github.io/ai/assets/images/organizations/techcrunch.com-50x50.jpg",
            "width": 50,
            "height": 50,
            "title": null,
            "attribution": null,
            "isCached": false
          }
        ],
        "publishers": null,
        "authors": null
      },
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Natural Language Processing",
        "AI"
      ]
    },
    {
      "path": "_news/2021-06-20-israels-immunai-to-use-215-mil-investment-to-develop-test-new-drugs.md",
      "title": "Israel’s Immunai to use $215 mil. investment to develop, test new drugs",
      "excerpt": "Israeli-American biotech company Immunai is best known for its development of the world’s largest data atlas of clinically annotated single-cell immune data.",
      "sourceUrl": null,
      "webUrl": "https://www.jpost.com/health-and-wellness/israels-immunai-to-use-215-mil-investment-to-develop-test-new-drugs-683266",
      "originalUrl": "https://www.jpost.com/health-and-wellness/israels-immunai-to-use-215-mil-investment-to-develop-test-new-drugs-683266",
      "featuredContent": null,
      "highlight": null,
      "heat": null,
      "tags": null,
      "images": [
        {
          "url": "https://images.jpost.com/image/upload/f_auto,fl_lossy/t_JM_ArticleMainImageFaceDetect/485949",
          "width": 640,
          "height": 428,
          "title": null,
          "attribution": null,
          "isCached": true
        }
      ],
      "content": "\r\n",
      "type": "article",
      "ampWebUrl": "https://m.jpost.com/health-and-wellness/israels-immunai-to-use-215-mil-investment-to-develop-test-new-drugs-683266/amp",
      "cdnAmpWebUrl": "https://m-jpost-com.cdn.ampproject.org/c/s/m.jpost.com/health-and-wellness/israels-immunai-to-use-215-mil-investment-to-develop-test-new-drugs-683266/amp",
      "publishedDateTime": "2021-06-19T13:00:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "The Jerusalem Post Blogs",
        "domain": "jpost.com",
        "images": null,
        "publishers": null,
        "authors": null
      },
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "AI"
      ]
    }
  ],
  "nextPage": null
}